KYMR: 5,000 common shares reported for sale
KYMR notice reports an intended sale of 5,000 shares of Common Stock by an issuer-related source on 06/25/2026, identified as resulting from an exercise of stock options with cash as the payment method.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KYMR notice reports an intended sale of 5,000 shares of Common Stock by an issuer-related source on 06/25/2026, identified as resulting from an exercise of stock options with cash as the payment method. The filing also lists multiple 10b5-1 sales by Noah Goodman totaling prior transactions on 04/09/2026, 04/10/2026, 04/14/2026, and 06/22/2026 with individual share amounts shown.
Insights
Form 144 lists an issuer-tied option exercise and multiple 10b5-1 sales by Noah Goodman.
The filing shows a planned sale of 5,000 shares on 06/25/2026 described as the exercise of stock options with cash proceeds. Separate rows list prior 10b5-1 sales by Noah Goodman on 04/09/2026, 04/10/2026, 04/14/2026, and 06/22/2026 with per-trade share counts and gross proceeds.
Timing and cash-flow recipients are stated where shown; cash is specified for the 06/25/2026 item. Further regulatory details (e.g., whether selling under a broker or exact transfer mechanics) are not included in the excerpt.
Multiple routine dispositions and an option exercise are recorded; this is administrative disclosure.
The entries list concrete share counts and gross amounts for each trade, including a 5,000-share option exercise and prior 10b5-1 transactions (e.g., 2,500 shares on 06/22/2026). These are transactional disclosures rather than company operational developments.
Subsequent filings or broker reports would clarify execution method and settlement; the excerpt does not provide proceeds allocation beyond the per-trade gross figures shown.
Key Figures
Key Terms
Form 144 regulatory
10b5-1 regulatory
exercise of stock options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who executed recent 10b5-1 sales disclosed in the KYMR filing?
Are proceeds recipients specified for the reported transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.